跳至主要内容
临床试验/IRCT20240525061893N1
IRCT20240525061893N1已完成2 期

Evaluation of dexamethasone solution efficacy on prevention of radiotherapy induced mucositis in patients with head and neck cancer

Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Performance level of KPS=70 (or ECOG score=0-1)
  • Newly diagnosed patient
  • Having a pathological diagnosis of head and neck cancer
  • Presence of adjuvant or definitive radiotherapy indication
  • The treatment dose is at least 60 Gry
  • Placement of at least half of the oral cavity in the radiotherapy treatment field

排除标准

  • Lack of consent to participate in the study
  • Presence of chronic kidney (eGFR <50 ml/min), heart (EF <50%) and liver diseases (liver enzyme levels > three times normal)
  • History of previous malignancy
  • History of previous radiation therapy in the head and neck area
  • History of hypersensitivity reaction to dexamethasone mouthwash

研究者

相似试验